Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;3(5):100403.
doi: 10.1016/j.ajogmf.2021.100403. Epub 2021 May 25.

COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women

Affiliations

COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women

Desmond Sutton et al. Am J Obstet Gynecol MFM. 2021 Sep.

Abstract

Background: Although mass vaccination against COVID-19 may prove to be the most efficacious end to this deadly pandemic, there remain concern and indecision among the public toward vaccination. Because pregnant and reproductive-aged women account for a large proportion of the population with particular concerns regarding vaccination against COVID-19, this survey aimed at investigating their current attitudes and beliefs within our own institution.

Objective: This study aimed to understand vaccine acceptability among pregnant, nonpregnant, and breastfeeding respondents and elucidate factors associated with COVID-19 vaccine acceptance.

Study design: We administered an anonymous online survey to all women (including patients, providers, and staff) at our institution assessing rates of acceptance of COVID-19 vaccination. Respondents were contacted in 1 of 3 ways: by email, advertisement flyers, and distribution of quick response codes at virtual town halls regarding the COVID-19 vaccine. Based on their responses, respondents were divided into 3 mutually exclusive groups: (1) nonpregnant respondents, (2) pregnant respondents, and (3) breastfeeding respondents. The primary outcome was acceptance of vaccination. Prevalence ratios were calculated to ascertain the independent effects of multiple patient-level factors on vaccine acceptability.

Results: The survey was administered from January 7, 2021, to January 29, 2021, with 1012 respondents of whom 466 (46.9%) identified as non-Hispanic White, 108 (10.9%) as non-Hispanic Black, 286 (28.8%) as Hispanic, and 82 (8.2%) as non-Hispanic Asian. The median age was 36 years (interquartile range, 25-47 years). Of all the respondents, 656 respondents (64.8%) were nonpregnant, 216 (21.3%) were pregnant, and 122 (12.1%) were breastfeeding. There was no difference in chronic comorbidities when evaluated as a composite variable (Table 1). A total of 390 respondents (39.2%) reported working in healthcare. Nonpregnant respondents were most likely to accept vaccination (457 respondents, 76.2%; P<.001) with breastfeeding respondents the second most likely (55.2%). Pregnant respondents had the lowest rate of vaccine acceptance (44.3%; P<.001). Prevalence ratios revealed all non-White races except for non-Hispanic Asian respondents, and Spanish-speaking respondents were less likely to accept vaccination (Table 3). Working in healthcare was not found to be associated with vaccine acceptance among our cohort.

Conclusion: In this survey study of only women at a single institution, pregnant respondents of non-White or non-Asian races were more likely to decline vaccination than nonpregnant and breastfeeding respondents. Working in healthcare was not associated with vaccine acceptance.

Keywords: COVID-19; breastfeeding; risk reduction; vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
All respondents declining vaccination were questioned on specific reasons for declination The bars represent the mean scores from 0 meaning “low or no concern” to 5 “highly concerned.”
Figure 2
Figure 2
All pregnant respondents declining vaccination were questioned on pregnancy-related reasons for declination The bars represent the mean scores from 0 meaning “low or no concern” to 5 “highly concerned.”
Figure 3
Figure 3
All respondents accepting vaccination were questioned on specific reasons for acceptance The bars represent the mean scores from 0 meaning “little or no influence” to 5 “strongly supports.”
Figure 4
Figure 4
All pregnant respondents accepting vaccination were questioned on pregnancy-related reasons for acceptance The bars represent the mean scores from 0 meaning “little or no influence” to 5 “strongly supports.”
Figure 5
Figure 5
All hesitant respondents were questioned on reasons for declination The bars represent the mean scores from 0 meaning “low or no concern” to 5 “highly concerned.”
Figure 6
Figure 6
All hesitant respondents were questioned on specific reasons for acceptance The bars represent the mean scores from 0 meaning “little or no influence” to 5 “strongly supports.”

References

    1. Ogedegbe G, Ravenell J, Adhikari S, et al. Assessment of racial/ethnic disparities in hospitalization and mortality in patients with COVID-19 in New York City. JAMA Netw Open. 2020;3 - PMC - PubMed
    1. Zambrano LD, Ellington S, Strid P, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1641–1647. - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed
    1. The American College of Obstetricians and Gynecologists; 2021. ACOG and SMFM joint statement on WHO recommendations Regarding COVID-19 vaccines and pregnant individuals.https://www.acog.org/news/news-releases/2021/01/acog-and-smfm-joint-stat... Available at: Accessed February 16, 2021.
    1. Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6:e210–e221. - PMC - PubMed

Substances